That likely only increases the appetite of biotech investors to bet on the next thing. But keep in mind the deal offers some ...
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell ...
On Monday, 10 November 2025, the healthcare world was abuzz as two pharmaceutical giants, Pfizer and Novo Nordisk, fiercely ...
The Hearty Soul on MSN
Study Suggests Possible Link Between Pfizer COVID-19 Vaccine and Vision-Related Eye Conditions
Using Your Credit Card at the Checkout Is Set to Get a Lot More Complicated At Kris Jenner's birthday bash in Beverly Hills, ...
Pfizer was poised to seal a takeover of Metsera on Saturday after its improved offer won over the biotechnology startup's ...
Pfizer has fended off Nova Nordisk for control of the next-gen weight-loss drug developer Metsera. Meanwhile, Resmed watches ...
By now, you know that the COVID-19 vaccine is the best way to protect against severe COVID infections and reduce your chances ...
The fate of the enhanced Affordable Care Act premium tax credits — initially bolstered during the pandemic — is still unclear ...
Barchart on MSN
Pfizer Stock: Is Wall Street Bullish or Bearish?
Pfizer has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s ...
Pfizer saw U.S. Comirnaty sales drop to $870 million in the recently completed third quarter from $1.16 billion in the same ...
The greater a company's earnings, the better its position will be to pay dividends. However, Pfizer's adjusted earnings per share (EPS) declined 18% year over year in Q3. That might seem to indicate ...
TipRanks on MSN
Pfizer files lawsuit against Metsera, its Directors and Novo Nordisk for breach of merger agreement
Pfizer has announced that it has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, S.A. in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback